SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-077792
Filing Date
2022-03-17
Accepted
2022-03-17 07:10:31
Documents
14
Period of Report
2022-03-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d326646d8k.htm   iXBRL 8-K 24644
2 EX-99.1 d326646dex991.htm EX-99.1 110924
6 GRAPHIC g326646g0317095116163.jpg GRAPHIC 4001
  Complete submission text file 0001193125-22-077792.txt   285365

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aadi-20220317.xsd EX-101.SCH 2848
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aadi-20220317_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aadi-20220317_pre.xml EX-101.PRE 11702
8 EXTRACTED XBRL INSTANCE DOCUMENT d326646d8k_htm.xml XML 3480
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38560 | Film No.: 22746711
SIC: 2834 Pharmaceutical Preparations